Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Payers
Evernorth's Accredo to offer Humira biosim at $0 out-of-pocket
Evernorth's Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs, the company announced on Thursday.
Paige Minemyer
Apr 25, 2024 4:30pm
Industry shook by CMS final rule on broker comp, health equity
Apr 5, 2024 1:02pm
Proposals on PBMs and medical devices advanced by House
Nov 16, 2023 7:25am
Senate votes to reform PBMs, stop $16B in hospital cuts
Nov 8, 2023 5:04pm
CMS targets predatory MA marketing, broker payments
Nov 6, 2023 5:31pm
CarelonRx the latest PBM to embrace Humira biosimilars
Oct 24, 2023 4:05pm